Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 12,122 $ 12,162
Trading marketable securities 7,211 11,951
Available-for-sale securities (amortized cost of $2,023 and $0, respectively) 1,989 0
Prepaid expenses and other current assets 826 496
Deferred offering costs 134 0
Total Current Assets 22,282 24,609
Intangible asset 2,039 2,039
Available-for-sale securities (amortized cost of $0 and $1,524, respectively) 0 1,519
Operating lease right-of-use assets 81 81
Other assets 3 3
TOTAL ASSETS 24,405 28,251
Current Liabilities    
Accounts payable and accrued liabilities 432 975
Due to related parties 50 21
Operating lease liabilities - current portion 45 31
Total Current Liabilities 527 1,027
Operating lease liabilities 40 57
TOTAL LIABILITIES 567 1,084
STOCKHOLDERS' EQUITY    
Preferred Stock, par value $0.001 per share, 6,250,000 shares authorized, 0 shares issued and outstanding 0 0
Common Stock, par value $0.001 per share, 750,000,000 shares authorized, 42,593,981 and 42,301,013 shares issued and outstanding, respectively 42 42
Additional paid-in capital 49,324 48,081
Accumulated deficit (25,352) (20,938)
Accumulated other comprehensive loss (176) (18)
Total Stockholders' Equity 23,838 27,167
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 24,405 $ 28,251